Physician profile
Matthew Risendal
NPI 1669904488
$4,309.04
in general payments reported to CMS, 2019-2025
33 companies · $592 in 2025
The $592 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $335 · 2022: $500 · 2023: $1,619 · 2024: $1,263 · 2025: $592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,374 · Education: $79.99 · Entertainment: $19.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,373.60 |
| Education | $79.99 |
| Entertainment | $19.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $701.20 | 2021-2025 | Spaceoar Vue System - 10ml, Upsylon, Axonics |
| Pfizer INC. | $521.26 | 2022-2025 | |
| Urogen Pharma, INC. | $376.28 | 2022-2025 | Jelmyto |
| Sumitomo Pharma America, INC. | $372.40 | 2023-2025 | Gemtesa, Orgovyx |
| Axonics, INC. | $349.28 | 2022-2024 | Axonics |
| Abbvie INC. | $290.89 | 2022-2025 | Botox |
| Accord Healthcare, INC. | $265.52 | 2023-2024 | |
| Procept Biorobotics Corporation | $137.33 | 2024 | Aquabeam System |
| Janssen Biotech, INC. | $135.12 | 2022-2024 | Erleada |
| Teleflex LLC | $119.40 | 2023 | Urolift |
| Endo USA, INC. | $113.34 | 2024-2025 | Aveed, Xiaflex |
| Dendreon Pharmaceuticals LLC | $111.31 | 2022-2025 | Provenge |
| Astellas Pharma US INC | $87.12 | 2023-2024 | Xtandi, Myrbetriq |
| Endo Pharmaceuticals INC. | $78.71 | 2022-2024 | Xiaflex, Aveed |
| Myovant Sciences INC. | $66.51 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $66.20 | 2023-2025 | |
| Ferring Pharmaceuticals INC. | $49.05 | 2024-2025 | Adstiladrin |
| C. R. Bard, INC. & Subsidiaries | $48.64 | 2023-2024 | |
| Blue Earth Diagnostics | $48.48 | 2022-2023 | |
| Laborie Medical Technologies Corp. | $43.14 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Ambu INC. | $41.99 | 2024 | |
| Urovant Sciences INC | $34.82 | 2022 | |
| Merck Sharp & Dohme LLC | $33.81 | 2025 | Zerbaxa |
| Tempus Ai, INC | $29.27 | 2024 | Xt Cdx |
| Medtronic, INC. | $28.45 | 2023 | Interstim |
| Antares Pharma, INC. | $25.02 | 2024 | Xyosted |
| Caldera Medical, INC | $24.45 | 2023 | Desara |
| Progenics Pharmaceuticals, INC. | $24.19 | 2025 | |
| Calyxo, INC. | $20.51 | 2024 | Cvac Aspiration System |
| Provepharm INC. | $19.97 | 2024 | Bludigo |
| Immunitybio, INC. | $16.32 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $15.56 | 2023 | Seglentis |
| Myriad Genetic Laboratories, INC. | $13.50 | 2023 | Prolaris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Risendal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.